Phibro Animal Health Corporation (PAHC)
PAHC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$36.81
-1.66% on the day
Market cap
$1.5B
Small cap
Revenue · 2025
$1.3B
+27.4% on 2024
Net income · 2025
$48.3M
3.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PAHC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001069899 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.3B |
| Net income | $48.3M |
| Operating income | $110.5M |
| Net margin | 3.7% |
| Operating margin | 8.5% |
| Revenue growth | +27.4% |
| Cash | $55.5M |
| Total assets | $1.4B |
| P/E (computed) | 31.0× |
| P/S (computed) | 1.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FINAL PROSPECTUS | 424B4 | 2014-04-14 |
| Latest annual report | 10-K | 2026-08-26 |
| Latest quarterly / interim | 10-Q | 2026-05-06 |
| Latest current report | 8-K | 2026-08-26 |
| Latest proxy | DEFA14A | 2026-09-18 |
Source: SEC EDGAR submissions feed, 770 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.7% |
| 1 month | +8.5% |
| 3 months | +10.1% |
| Year to date | +1.7% |
| 1 year | +3.9% |
| From 52-week high | -36.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| INVA | Innoviva Inc. | $20.74 | -3.31% | $1.5B |
| QURE | uniQure N.V. | $21.28 | -2.56% | $1.5B |
| RARE | Ultragenyx Pharmaceutical Inc. | $14.92 | -2.48% | $1.5B |
| ETON | Eton Pharmaceuticals Inc. | $53.33 | -3.48% | $1.5B |
| STOK | Stoke Therapeutics Inc. | $22.50 | -6.83% | $1.5B |
| CMPS | COMPASS Pathways Plc American Depository Shares | $11.14 | -3.38% | $1.5B |
| PCRX | Pacira BioSciences Inc. | $36.31 | -0.11% | $1.4B |
| KRSA | Korsana Biosciences Inc. | $31.66 | -6.99% | $1.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier